# Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx

> **NCT00004227** · PHASE3 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 32 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** cetuximab
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00004227
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-04
- **Primary completion:** 2007-03
- **Final completion:** 2008-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004227, "Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*